peptide selected from the group consisting of peptide glp-1, peptide gip and their dipeptidyl peptidase iv (dpp-iv) resistant analogs; and pharmaceutical composition

摘要

peptide selected from the group consisting of peptide glp-1, peptide gip and their dipeptidyl peptidase iv resistant analogues (dpp-iv); and pharmaceutical composition the present invention relates to the use of glucagon or glp-1-like peptide-1 incretin hormones and glucose or gip-dependent insulinotropic polypeptide, or analogs thereof, particularly dipeptidyl peptidase iv resistant analogues, in the treatment osteoarthritis, particularly to inhibit or retard the destruction of cartilage. 1/1